Patent · US Active

Vaccinia virus H3L and B5R specific monoclonal antibodies and methods of making and using same

US8623370B2 · kind B2 · utility

1Cited by

1References

25Claims

0Family size

Assignees

KYOWA HAKKO KIRIN CO., LTD. · JP
LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY · US

Inventors

Shinichiro Kato · Kariya, JP
Steve Granger · Encinitas, US
Shane Crotty · San Diego, US
Sandra Rickert · Encinitas, US
Lilia Koriazova · San Diego, US
Tomoyuki Tahara · Tokyo, JP

Key dates

Filing date	Oct 6, 2008
Grant date	Jan 7, 2014
Priority date	—
Expiry date	Mar 10, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/734
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to antibodies and subsequences thereof that specifically bind to poxvirus B5R envelope protein, antibodies and subsequences thereof that specifically bind to pox virus H3L envelope protein, and combinations thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.